Concepts (87)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Naltrexone | 3 | 2021 | 70 | 1.380 |
Why?
|
| Hyperinsulinism | 1 | 2020 | 71 | 0.670 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2021 | 152 | 0.640 |
Why?
|
| Stilbenes | 1 | 2017 | 42 | 0.520 |
Why?
|
| Insulin Resistance | 2 | 2020 | 700 | 0.490 |
Why?
|
| Diabetic Nephropathies | 1 | 2017 | 113 | 0.490 |
Why?
|
| NF-kappa B | 1 | 2017 | 483 | 0.440 |
Why?
|
| Transcription Factor RelA | 2 | 2021 | 57 | 0.340 |
Why?
|
| Glucagon-Like Peptide-1 Receptor | 2 | 2022 | 41 | 0.340 |
Why?
|
| Drug Design | 2 | 2022 | 168 | 0.310 |
Why?
|
| Molecular Docking Simulation | 2 | 2020 | 127 | 0.310 |
Why?
|
| Hep G2 Cells | 3 | 2021 | 98 | 0.250 |
Why?
|
| Nuclear Receptor Subfamily 1, Group D, Member 1 | 1 | 2025 | 23 | 0.240 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2020 | 1735 | 0.230 |
Why?
|
| Physical Conditioning, Animal | 1 | 2025 | 99 | 0.220 |
Why?
|
| Habenula | 1 | 2024 | 43 | 0.210 |
Why?
|
| Light | 1 | 2024 | 183 | 0.210 |
Why?
|
| Adaptation, Physiological | 1 | 2025 | 289 | 0.210 |
Why?
|
| Oligochaeta | 1 | 2022 | 1 | 0.200 |
Why?
|
| Tigers | 1 | 2022 | 1 | 0.200 |
Why?
|
| Oryza | 1 | 2022 | 29 | 0.200 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2022 | 1419 | 0.170 |
Why?
|
| Lipogenesis | 1 | 2021 | 59 | 0.170 |
Why?
|
| Inflammation | 2 | 2020 | 1595 | 0.170 |
Why?
|
| RAW 264.7 Cells | 1 | 2020 | 47 | 0.170 |
Why?
|
| Insulin-Secreting Cells | 1 | 2022 | 150 | 0.170 |
Why?
|
| Dietary Carbohydrates | 1 | 2021 | 117 | 0.170 |
Why?
|
| Sirtuin 1 | 1 | 2020 | 55 | 0.160 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2021 | 189 | 0.150 |
Why?
|
| Zinc Oxide | 1 | 2019 | 12 | 0.150 |
Why?
|
| Enzyme Activators | 1 | 2019 | 12 | 0.150 |
Why?
|
| Protein Binding | 2 | 2020 | 1860 | 0.150 |
Why?
|
| Muscle, Skeletal | 1 | 2025 | 1043 | 0.150 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2020 | 204 | 0.150 |
Why?
|
| Feeding Behavior | 1 | 2024 | 731 | 0.150 |
Why?
|
| Cell Nucleus | 1 | 2021 | 691 | 0.140 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2018 | 117 | 0.140 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2019 | 182 | 0.140 |
Why?
|
| Alloxan | 1 | 2017 | 3 | 0.130 |
Why?
|
| Malondialdehyde | 1 | 2017 | 62 | 0.130 |
Why?
|
| Animals | 8 | 2025 | 36521 | 0.130 |
Why?
|
| Liver | 2 | 2021 | 1876 | 0.130 |
Why?
|
| Superoxide Dismutase | 1 | 2017 | 185 | 0.120 |
Why?
|
| Rats, Wistar | 1 | 2017 | 398 | 0.120 |
Why?
|
| Nanoparticles | 1 | 2019 | 289 | 0.120 |
Why?
|
| Glutathione | 1 | 2017 | 201 | 0.120 |
Why?
|
| Rats | 2 | 2024 | 3876 | 0.120 |
Why?
|
| Antioxidants | 1 | 2017 | 373 | 0.110 |
Why?
|
| Glomerular Filtration Rate | 1 | 2017 | 542 | 0.100 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2019 | 429 | 0.100 |
Why?
|
| Mice | 4 | 2025 | 19045 | 0.100 |
Why?
|
| Oxidative Stress | 1 | 2017 | 874 | 0.090 |
Why?
|
| Kidney | 1 | 2017 | 1404 | 0.080 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 4802 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 3 | 2025 | 4882 | 0.080 |
Why?
|
| Male | 4 | 2025 | 66197 | 0.070 |
Why?
|
| Muscle Contraction | 1 | 2025 | 174 | 0.060 |
Why?
|
| Darkness | 1 | 2024 | 27 | 0.060 |
Why?
|
| Dorsal Raphe Nucleus | 1 | 2024 | 16 | 0.060 |
Why?
|
| Circadian Clocks | 1 | 2025 | 72 | 0.060 |
Why?
|
| Serotonergic Neurons | 1 | 2024 | 24 | 0.060 |
Why?
|
| Humans | 6 | 2024 | 134196 | 0.050 |
Why?
|
| Poultry | 1 | 2022 | 8 | 0.050 |
Why?
|
| Manure | 1 | 2022 | 6 | 0.050 |
Why?
|
| Circadian Rhythm | 1 | 2025 | 298 | 0.050 |
Why?
|
| Fatty Acids | 1 | 2025 | 372 | 0.050 |
Why?
|
| Neural Pathways | 1 | 2024 | 283 | 0.050 |
Why?
|
| Streptozocin | 1 | 2022 | 28 | 0.050 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2025 | 396 | 0.050 |
Why?
|
| Soil | 1 | 2022 | 72 | 0.050 |
Why?
|
| Glucagon | 1 | 2022 | 184 | 0.050 |
Why?
|
| Eating | 1 | 2024 | 395 | 0.050 |
Why?
|
| Cattle | 1 | 2022 | 589 | 0.040 |
Why?
|
| Nerve Net | 1 | 2024 | 259 | 0.040 |
Why?
|
| Glycation End Products, Advanced | 1 | 2021 | 30 | 0.040 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2021 | 132 | 0.040 |
Why?
|
| Repressor Proteins | 1 | 2025 | 874 | 0.040 |
Why?
|
| Hydrogen Bonding | 1 | 2018 | 87 | 0.040 |
Why?
|
| Bone and Bones | 1 | 2021 | 311 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2018 | 318 | 0.040 |
Why?
|
| Drug Discovery | 1 | 2018 | 179 | 0.030 |
Why?
|
| Diet, High-Fat | 1 | 2019 | 241 | 0.030 |
Why?
|
| Ligands | 1 | 2018 | 573 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2025 | 4012 | 0.030 |
Why?
|
| Insulin | 1 | 2022 | 1260 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2019 | 4936 | 0.020 |
Why?
|
| Female | 1 | 2022 | 72037 | 0.010 |
Why?
|